AprilBio Co.,Ltd. (KOSDAQ: 397030)

Market Cap	432.86B
Revenue	n/a
Net Income	n/a
Shares Out	21.92M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	295,157
Open	20,200
Previous Close	20,250
Day's Range	19,900 - 20,650
52-Week Range	10,200 - 26,450
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About AprilBio Co.,Ltd.

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030